Psychiatr. praxi. 2015;16(3):79-82

Optimising treatment in Alzheimer’s disease

MUDr.Vanda Franková
Psychiatrická nemocnice v Dobřanech

The first step in Alzheimer’s disease treatment is an accurate diagnosis and recognition of all symptoms of the disorder. Management

should start as soon as possible, optimally in the initial stage of the disease. The approach has to be complex, person-centred and

conclude not only the patient but also his family/caregivers. Careful assessment for any comorbidities, their treatment and programming

meaningful activities is necessary. Management of problem behaviors begins with a careful search for triggers and causative factors,

where possible should be non-pharmacological. Cholinesterase inhibitors and memantine are recommended for Alzheimer’s disease



treatment: In the terminal stage of dementia the palliative approach should be considered.

Keywords: Alzheimer’s disease, treatment, cholinesterase inhibitors, memantine

Published: December 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Franková V. Optimising treatment in Alzheimer’s disease. Psychiatr. praxi. 2015;16(3):79-82.
Download citation

References

  1. Jirák R. Gerontopsychiatrie. 1. vyd. Praha: Galén 2013.
  2. Vyhnálek M, Bartoš A, et al. Diagnostikujeme a léčíme demence správně a včas? Výsledky průzkumu ve světle nových doporučení. Neurologie pro praxi 2011; 12(5): 352-358. Go to original source...
  3. Franková V, Hort J, et al. Alzheimerova demence v praxi: konsenzus psychiatricko-neurologicko-geriatrický. 1. vyd. Praha: Mladá fronta, 2011.
  4. Jirák R, Franková V. Organické duševní poruchy. In: Raboch J, Uhlíková P, et al., eds. Psychiatrie: Doporučené postupy psychiatrické péče IV. Praha: Česká psychiatrická společnost 2014; 9-34.
  5. Rusina R, Rusinová K, et al. Léčba pokročilé demence - paliativní přístup. Neurol pro praxi 2010; 11(1): 16-19.
  6. Volicer L. Palliative care and hospice. In: Agronin ME, Maletta GJ. eds. Principles and practice of geriatric psychiatry. 2nd ed. USA: Lippincott Williams & Wilkins 2011; 251-264.
  7. Hort J, O'Brien JT, et al. EFNS Scientist Panel on Dementia. EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol 2010; 17(10): 1236-1248. Go to original source... Go to PubMed...
  8. Volicer L. Treatment of behavioural disorders. In: Sinclair AJ, Morley JE, Vellas B, eds. Pathy's principles and practice of geriatric medicine. 5th ed. UK: John Wiley & Sons, Ltd 2012; 2: 961-975. Go to original source...
  9. Volicer L, Frijters DHM, Van der Steen JT. Relationship between symptoms of depression and agitation in nursing home residents with dementia. Int J Geriatr Psychiatry 2012; 27: 749-754. Go to original source... Go to PubMed...




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.